Reginald V. Lord

8.4k total citations · 2 hit papers
124 papers, 5.7k citations indexed

About

Reginald V. Lord is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Reginald V. Lord has authored 124 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Surgery, 41 papers in Pulmonary and Respiratory Medicine and 27 papers in Molecular Biology. Recurrent topics in Reginald V. Lord's work include Esophageal Cancer Research and Treatment (47 papers), Esophageal and GI Pathology (32 papers) and Gastric Cancer Management and Outcomes (24 papers). Reginald V. Lord is often cited by papers focused on Esophageal Cancer Research and Treatment (47 papers), Esophageal and GI Pathology (32 papers) and Gastric Cancer Management and Outcomes (24 papers). Reginald V. Lord collaborates with scholars based in Australia, United States and Germany. Reginald V. Lord's co-authors include Tom R. DeMeester, Jeffrey H. Peters, Katherine Samaras, Kathleen D. Danenberg, Peter V. Danenberg, Steven R. DeMeester, Kumari Wickramasinghe, Jan Brabender, Peter F. Crookes and Natalia K. Botelho and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Reginald V. Lord

118 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

De novo identification of differentially methylated regions in the human genome

2015 571 citations Katherine Samaras, Reginald V. Lord et al. profile →
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

2002 551 citations Reginald V. Lord, Jan Brabender et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reginald V. Lord Australia	38	2.5k	2.3k	1.5k	1.0k	716	124	5.7k
Guido Biasco Italy	40	1.8k 0.7×	1.1k 0.5×	1.8k 1.2×	1.5k 1.5×	1.5k 2.0×	253	5.4k
K.E. Behrns United States	39	3.5k 1.4×	878 0.4×	946 0.6×	1.7k 1.6×	463 0.6×	234	5.9k
Xinyu Qin China	33	1.4k 0.6×	887 0.4×	1.2k 0.8×	1.3k 1.3×	764 1.1×	131	4.0k
Helen Heneghan Ireland	35	2.5k 1.0×	1.7k 0.7×	640 0.4×	1.2k 1.2×	157 0.2×	108	5.3k
Hubert Piessevaux Belgium	33	2.4k 1.0×	541 0.2×	1.6k 1.1×	2.1k 2.0×	2.3k 3.2×	128	5.8k
Elfriede Bollschweiler Germany	46	4.9k 2.0×	819 0.4×	4.3k 2.8×	1.4k 1.3×	913 1.3×	195	7.1k
Yanhong Deng China	38	1.2k 0.5×	1.2k 0.5×	1.2k 0.8×	2.3k 2.2×	179 0.3×	284	5.2k
Åke Andrén‐Sandberg Sweden	42	3.7k 1.5×	904 0.4×	1.3k 0.8×	3.9k 3.8×	203 0.3×	204	6.3k
Peter Muscarella United States	29	1.5k 0.6×	925 0.4×	887 0.6×	1.5k 1.4×	228 0.3×	105	3.6k
Mark W. Russo United States	32	1.3k 0.5×	815 0.3×	496 0.3×	679 0.7×	520 0.7×	101	4.3k

Countries citing papers authored by Reginald V. Lord

Since Specialization

Citations

This map shows the geographic impact of Reginald V. Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reginald V. Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reginald V. Lord more than expected).

Fields of papers citing papers by Reginald V. Lord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reginald V. Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reginald V. Lord. The network helps show where Reginald V. Lord may publish in the future.

Co-authorship network of co-authors of Reginald V. Lord

This figure shows the co-authorship network connecting the top 25 collaborators of Reginald V. Lord. A scholar is included among the top collaborators of Reginald V. Lord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reginald V. Lord. Reginald V. Lord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Wendy, et al.. (2024). A junior doctor led near-peer acute ENT/head and neck surgery workshop for medical students. Surgery Open Science. 20. 7–13.

Sanagapalli, Santosh, Andrew Plumb, Reginald V. Lord, & Rami Sweis. (2023). How to effectively use and interpret the barium swallow: Current role in esophageal dysphagia. Neurogastroenterology & Motility. 35(10). e14605–e14605. 6 indexed citations

Na, Renhua, Kyoko Miura, Suzanne O’Brien, et al.. (2020). Clinical pathways and outcomes of patients with Barrett’s esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008–2016. Diseases of the Esophagus. 34(8). 2 indexed citations

Shah, Alok K., Günter Härtel, Ian Brown, et al.. (2018). Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus. Molecular & Cellular Proteomics. 17(12). 2324–2334. 24 indexed citations

Mååg, Jesper L.V., Oliver M. Fisher, Angelique Levert‐Mignon, et al.. (2017). Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing. Molecular Cancer Research. 15(11). 1558–1569. 32 indexed citations

Fisher, Oliver M., Sarah J. Lord, Dan Falkenback, et al.. (2016). The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis. Gut. 66(3). 399–410. 30 indexed citations

Levert‐Mignon, Angelique, Michael J. Bourke, Sarah J. Lord, et al.. (2016). Changes in gene expression of neo‐squamous mucosa after endoscopic treatment for dysplastic Barrett’s esophagus and intramucosal adenocarcinoma. United European Gastroenterology Journal. 5(1). 13–20. 1 indexed citations

Farey, John, Oliver M. Fisher, Angelique Levert‐Mignon, et al.. (2016). Effect of Laparoscopic Sleeve Gastrectomy on Fasting Gastrointestinal, Pancreatic, and Adipose-Derived Hormones and on Non-Esterified Fatty Acids. Obesity Surgery. 27(2). 399–407. 32 indexed citations

Lim, Choon Pin, Oliver M. Fisher, Dan Falkenback, et al.. (2015). Bariatric Surgery: A ‘Bridge to Transplant’ for Morbidly Obese Patients With Advanced Heart Failure. The Journal of Heart and Lung Transplantation. 34(4). S184–S184. 1 indexed citations

10.

Bahin, Farzan F., Mahesh Jayanna, Luke F. Hourigan, et al.. (2015). Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett’s esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma. Gastrointestinal Endoscopy. 83(1). 68–77. 22 indexed citations

11.

Fisher, Oliver M., Angelique Levert‐Mignon, Sarah J. Lord, et al.. (2014). High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett’s Esophagus and Adenocarcinoma. Annals of Surgical Oncology. 22(7). 2431–2438. 13 indexed citations

12.

Church, Jody, et al.. (2013). Cost-Effectiveness Of Radiofrequency Ablation Compared To Endoscopic Surveillance For Patients With Barrett's Esophagus With Low Grade Dysplasia. Value in Health. 16(3). A215–A215. 1 indexed citations

13.

Phillips, Wayne A., Reginald V. Lord, Derek J. Nancarrow, David I. Watson, & David C. Whiteman. (2010). Barrett's esophagus. Journal of Gastroenterology and Hepatology. 26(4). 639–648. 45 indexed citations

14.

Botelho, Natalia K., Sarah J. Lord, Sonika Tyagi, et al.. (2010). Gene expression alterations in formalin-fixed, paraffin-embedded Barrett esophagus and esophageal adenocarcinoma tissues.. Cancer Biology & Therapy. 10(2). 172–179. 18 indexed citations

15.

Yu, Hong, et al.. (2009). Effectiveness of HSV-tk Suicide Gene Therapy Driven by the Grp78 Stress-Inducible Promoter in Esophagogastric Junction and Gastric Adenocarcinomas. Journal of Gastrointestinal Surgery. 13(6). 1044–1051. 21 indexed citations

16.

DeMeester, Steven R., Kumari Wickramasinghe, Reginald V. Lord, et al.. (2002). Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. The American Journal of Gastroenterology. 97(10). 2514–2523. 68 indexed citations

17.

Lord, Reginald V., Anna Kaminski, Stefan Öberg, et al.. (2002). Absence of Gastroesophageal Reflux Disease in a Majority of Patients Taking Acid Suppression Medications After Nissen Fundoplication. Journal of Gastrointestinal Surgery. 6(1). 3–10. 135 indexed citations

18.

Brabender, Jan, Reginald V. Lord, Kumari Wickramasinghe, et al.. (2002). Glutathione S–Transferase-Pi Expression Is Downregulated in Patients With Barrett's Esophagus and Esophageal Adenocarcinoma. Journal of Gastrointestinal Surgery. 6(3). 359–367. 41 indexed citations

19.

Brabender, Jan, Jimin Park, Ralf Metzger, et al.. (2002). Prognostic Significance of Cyclooxygenase 2 mRNA Expression in Non-Small Cell Lung Cancer. Annals of Surgery. 235(3). 440–443. 101 indexed citations

20.

Lord, Reginald V.. (1998). Incidence of Deep Vein Thrombosis After Laparoscopic vs Minilaparotomy Cholecystectomy. Archives of Surgery. 133(9). 967–967. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact